U2Bio Co., Ltd. (KOSDAQ:221800)

South Korea · Delayed Price · Currency is KRW

26,850

+900 (3.47%)

At close: Feb 26, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
General Diagnostic Examination	11.47B
General Diagnostic Examination Growth	5.92%
General Diagnostic Test Reagents, Etc.	7.57B
General Diagnostic Test Reagents, Etc. Growth	5.47%
Molecular Diagnostic Testing	2.21B
Molecular Diagnostic Testing Growth	-50.26%
Medical Information Technology Solutions Service	1.14B
Medical Information Technology Solutions Service Growth	-35.56%
Molecular Diagnostic Test Reagents, Etc.	65.01M
Molecular Diagnostic Test Reagents, Etc. Growth	-97.09%
Medical Information Technology Solutions Merchandise	40.42M
Medical Information Technology Solutions Merchandise Growth	-26.04%
Other	2.55B
Other Growth	-40.57%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	24.80B
South Korea Growth	-18.85%
Overseas	241.63M
Overseas Growth	3.58%